| Melting Point | 204–205°C |
| Color | Undesignated |
| Formula Weight | 131.18 |
| Physical Form | Crystal-powder at 20°C |
| Chemical Name or Material | 6-Aminohexanoic Acid |
| Molecular Formula | C6H13NO2 |
| Molecular Weight | 131.18 g/mol |
| CAS Number | 60-32-2 |
| EC Number | 200-469-3 |
| PubChem CID | 564 |
| InChIKey | SLXKOJJOQWFEFD-UHFFFAOYSA-N |
6-Aminocaproic Acid, also called ε-aminocaproic acid, is a straight-chain amino acid analogue built from a six-carbon chain carrying an amine group at one end and a carboxylic acid at the other. It’s structurally related to lysine and functions pharmacologically as a competitive inhibitor of plasmin, the enzyme responsible for breaking down blood clots (fibrinolysis) — the mechanism behind its use as the active ingredient in the antifibrinolytic drug Amicar. Sarchem Labs supplies it as a bulk research/technical-grade chemical, not that finished drug product.
In biochemical research, 6-aminocaproic acid is used to study and inhibit plasmin and related proteases, supporting fibrinolysis and coagulation-pathway research. Pharmaceutical R&D teams use bulk-grade material for early formulation and analytical work related to its antifibrinolytic mechanism. Separately, its structural relationship to caprolactam (the ring-opened form of the nylon-6 monomer) makes it relevant to polymer chemistry research exploring nylon-6 and related polyamide chemistry.
*No formal GHS pictogram/signal word data was located specifically for this compound in the sources checked; it generally presents a low chemical-hazard profile as a simple amino acid derivative. Confirm against Sarchem’s own SDS before publishing a specific hazard classification.*
No related products found.
In research, it's used to study plasmin inhibition and fibrinolysis/coagulation pathways, and in pharmaceutical R&D related to antifibrinolytic mechanisms; it's also relevant to nylon-6-related polymer chemistry research.
Chemically the same molecule, but Sarchem supplies it as a bulk research/technical-grade chemical — not the finished, FDA-approved Amicar drug product, which requires separately sourced, regulatory-approved material.
It competitively inhibits plasmin, the enzyme that breaks down fibrin clots, which is why the pharmaceutical form is used clinically to help control certain types of excessive bleeding.
60-32-2, C6H13NO2, molecular weight 131.18 g/mol.
Yes, for every lot (SKU S2195), confirming identity and purity before use in research applications.